Particulate hybrid HIV antigens
US4918166A · kind A · utility
53Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 26, 1987 |
| Grant date | Apr 17, 1990 |
| Priority date | — |
| Expiry date | Oct 26, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/826
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
Fusion proteins comprise a77 first amino acid sequence and a second amino acid sequence. The first amino acid sequence is derived from a retrotransposon or an RNA retrovirus and confers on the fusion protein the ability to assemble into particles; an example is the product of the YTA gene of the yeast retrotransposon Ty. The second amino acid sequence is an HIV antigen. So particles formed of the fusion proteins may be useful in vaccines or in diagnostic or purification applications.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.